Clinical Trial Update: A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 dose-escalation trial evaluating intravitreal Sirna-027 in patients with subfoveal choroidal neovascularization secondary to age-related m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Choroidal Neovascularization

Drugs mentioned

• Sirna-027 (sirna-027)

Snippet

Sponsor: Allergan | Conditions: Age-Related Macular Degeneration, Choroidal Neovascularization | Phase 1, Phase 2 | Status: COMPLETED